Frank Stenner
- Immunology top 2%
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 13
- Neutropenia and Cancer Infections 7
-
- Monoclonal and Polyclonal Antibodies Research 8
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
- Molecular Biology top 5%
-
- Lymphoma Diagnosis and Treatment 19
-
- Prostate Cancer Treatment and Research 13
- Renal cell carcinoma treatment 8
-
- Bladder and Urothelial Cancer Treatments 8
Frank Stenner
104 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Immunology 1.2k
- Oncology 1.1k
- Radiology, Nuclear Medicine and Imaging 617
- Cancer Research 313
- Molecular Biology 1.4k
Countries citing papers authored by Frank Stenner
This map shows the geographic impact of Frank Stenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Stenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Stenner more than expected).
Fields of papers citing papers by Frank Stenner
This network shows the impact of papers produced by Frank Stenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Stenner. The network helps show where Frank Stenner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Frank Stenner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 14 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 2 | |
| 11 | 2017 | 41 | |
| 12 | 2013 | 4 | |
| 13 | 2013 | 8 | |
| 14 | 2011 | 29 | |
| 15 | 2011 | 15 | |
| 16 | 2009 | 90 | |
| 17 | 2008 | 56 | |
| 18 | 2006 | 178 | |
| 19 | 2005 | 95 | |
| 20 | 2002 | 37 |
About Frank Stenner
Frank Stenner is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology, having authored 108 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (19 papers), Cancer Immunotherapy and Biomarkers (13 papers), Prostate Cancer Treatment and Research (13 papers), Renal cell carcinoma treatment (8 papers), Cancer Genomics and Diagnostics (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Neutropenia and Cancer Infections (7 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.1k citations) and Radiology, Nuclear Medicine and Imaging (617 citations). Frank Stenner has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Michael Pfreundschuh, Uğur Şahin, Ö. Türeci, Guorong Luo, Tanja Johannes, Holger Schmitt, B. Cochlovius, Rudolf Schmits, Heike Liewen and Christoph Renner. Their work appears in journals such as Journal of Clinical Oncology, Swiss Medical Weekly, Annals of Oncology, Oncology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.